Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Filters applied. Clear all
. 2019 Nov;183:124-130.
doi: 10.1016/j.thromres.2019.09.034. Epub 2019 Oct 23.

Cardiovascular Event Rates and Trajectories of LDL-cholesterol Levels and Lipid-Lowering Therapy in Patients With Atherosclerotic Cardiovascular Disease: A Population-Based Cohort Study

Affiliations

Cardiovascular Event Rates and Trajectories of LDL-cholesterol Levels and Lipid-Lowering Therapy in Patients With Atherosclerotic Cardiovascular Disease: A Population-Based Cohort Study

Jens Sundbøll et al. Thromb Res. .

Abstract

Background: An understanding of cardiovascular event rates and low-density lipoprotein cholesterol (LDL-C) levels and trajectories in patients with atherosclerotic cardiovascular disease is needed to evaluate treatment goals and adherence to guidelines.

Methods: We conducted a population-based cohort study in the North and Central Denmark Regions. Patients with prevalent atherosclerotic cardiovascular disease (myocardial infarction, non-hemorrhagic stroke, or peripheral artery disease) during 2006-2009 were identified. All patients received lipid-lowering therapy (statins or ezetimibe) and had LDL-C levels ≥1.8 mmol/L at baseline (January 1, 2010). We followed patients for 6 years until a primary composite outcome of cardiovascular death, myocardial infarction, non-hemorrhagic stroke, hospitalization for unstable angina, or coronary revascularization. Additionally, we characterized changes in LDL-C levels and use of statins during follow-up.

Results: The study included 10,772 patients (median age 69.2 years, 60.4% male). The overall event rate for the primary outcome was 62.7 (95% confidence interval: 59.2-66.2) per 1000 person-years. This event rate was higher among men than among women and increased with age and baseline LDL-C levels. Approximately 25% of patients with LDL-C measurements during follow-up achieved LDL-C levels below 1.8 mmol/L. Of the approximately two-thirds of patients using statins at the end of follow-up, nearly all patients (97%) received high-intensity therapy.

Conclusions: In this population of patients with atherosclerotic cardiovascular disease, we found high cardiovascular event rates, which increased with baseline LDL-C levels. Although most patients were on high-intensity statin therapy at end of follow-up, only one-quarter reached the guideline-recommended target LDL-C level ≤ 1.8 mmol/L.

Keywords: Atherosclerosis; Epidemiology; Lipids; Rehabilitation.

Similar articles

See all similar articles

MeSH terms

Substances

LinkOut - more resources

Feedback